Roche's IMpassion130 Is First Positive Phase III Immunotherapy Study In Triple Negative Breast Cancer

 
• By Sten Stovall
Mammography test
Tecentriq posts positive results in triple negative breast cancer • Source: Shutterstock

More from Immuno-oncology

More from Anticancer